1. Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis
- Author
-
Tae-Beom Ahn, Dallah Yoo, and Jae Young Joo
- Subjects
Pathology ,medicine.medical_specialty ,Ataxia ,Movement disorders ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Cerebrospinal fluid ,medicine ,RC346-429 ,glial fibrillary acidic protein (gfap) ,Autoimmune encephalitis ,Glial fibrillary acidic protein ,biology ,business.industry ,Autoantibody ,Meningoencephalitis ,choreoballism ,medicine.disease ,autoimmune encephalitis ,dyskinesia ,Neurology ,Dyskinesia ,nervous system ,biology.protein ,Neurology (clinical) ,Neurology. Diseases of the nervous system ,medicine.symptom ,business ,RC321-571 - Abstract
Movement disorders associated with glial fibrillary acidic protein (GFAP) autoantibodies have rarely been reported as ataxia or tremors. A 32-year-old man with headache and fever, initially diagnosed with viral meningoencephalitis, showed gradual improvement with empirical treatment. Two weeks after the illness, he suddenly developed orofacial, tongue, and neck dyskinesia accompanied by oculomotor abnormalities, which developed into severe generalized choreoballism. Brain magnetic resonance imaging (fluid-attenuated inversion recovery) showed signal hyperintensities in the bilateral globus pallidus interna. The clinical picture suggested an acute inflammatory trigger of secondary autoimmune encephalitis. The autoimmune antibody test was positive for GFAP, with the strongest reactivity in the cerebrospinal fluid (CSF) before treatment and decreased reactivity in serial CSF examinations during immunotherapy. Dyskinesia gradually improved to the extent that it could be controlled with only oral medications. This patient presented with parainfectious GFAP meningoencephalitis with distinctive clinical features and imaging findings.
- Published
- 2022